GlassScriptPhysician profile
Anna P Abalos
NPI 1720200017
$8,508.52
in general payments reported to CMS, 2019-2025
43 companies · $846 in 2025
The $846 reported for 2025 was more than what 83% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,238 · 2020: $1,381 · 2021: $1,516 · 2022: $1,606 · 2023: $1,194 · 2024: $728 · 2025: $846.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,768.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,768.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $934.74 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $808.65 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Glaxosmithkline, LLC. | $702.81 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Baxter Healthcare | $643.00 | 2022 | |
| Welch Allyn | $643.00 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $607.42 | 2019-2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $583.63 | 2021-2025 | |
| Abbvie INC. | $565.73 | 2021-2025 | Qulipta, Ubrelvy |
| Allergan, INC. | $351.58 | 2019-2020 | |
| Novo Nordisk INC | $295.84 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Merck Sharp & Dohme LLC | $288.13 | 2019-2021 | |
| Exact Sciences Corporation | $221.16 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Lilly USA, LLC | $208.10 | 2019-2024 | Zepbound, Jardiance |
| Sanofi-Aventis U.S. LLC | $180.09 | 2019-2022 | |
| Amarin Pharma, INC. | $149.10 | 2019-2021 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Abalos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.